Fixation and reversion of mutations in the receptor-binding domain of the SARS-CoV-2 spike protein: A 2020–2024 analysis
Authors:
Open Access
- 30 December 2024
- journal article
- Published by Elsevier in Journal of Virus Eradication
- Vol. 10 (4) , 100581
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
This publication has 5 references indexed in Scilit:
- An update on the anti-spike monoclonal antibody pipeline for SARS-CoV-2Clinical Microbiology and Infection, 2024
- Fixation and reversion of mutations in the receptor-binding domain of SARS-CoV-2 spike proteinDiagnostic Microbiology and Infectious Disease, 2023
- mRNA vaccines as an armor to combat the infectious diseasesTravel Medicine and Infectious Disease, 2023
- Monoclonal antibody therapies against SARS-CoV-2The Lancet Infectious Diseases, 2022
- CoV-Spectrum: analysis of globally shared SARS-CoV-2 data to identify and characterize new variantsBioinformatics, 2021